EI
PRDS

Ellevest Inc’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Ellevest Inc’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30
Closed -$40 – 1809
2023
Q1 		$40 Sell
30
-419
-93% -$685 ﹤0.01% 1830
2022
Q4 		$759 Buy
449
+430
+2,263% +$545 ﹤0.01% 1563
2022
Q3 		$0 Buy
+19
New +$57 ﹤0.01% 1945

Other funds holding PRDS

FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Ellevest Inc's PRDS Position: Q2 2023 in Review

Ellevest Inc sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q2 2023, closing a stake of 30 shares — an estimated $40 sold.

Ellevest Inc first reported a position in PRDS in Q3 2022 and held it in 3 quarters. The position peaked at $759 in Q4 2022. 59 funds tracked by Wall St. Rank hold PRDS as of Q2 2023.

  • Ellevest Inc reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 30 Pardes Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $40.
  • Ellevest Inc first reported a position in Pardes Biosciences, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • Ellevest Inc's Pardes Biosciences, Inc. Common Stock position peaked at $759 in Q4 2022.
  • 59 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.